Eirexpat, good to hear from you after all this time. I feel your frustration, like a lot of other shareholders I bought a lot of shares at $3.00 and to watch them fall to .007 cents is ...... I do however feel the pain is nearly over.
The data is in. There is no need to spin it and blow our own trumpet by employing a PR firm to soak up more funds. We need to get in front of a handful of key decision makers from big pharma and nut out a deal. Ferghana partners and Seth Yakatan ( US based) should be able to organize meetings and Brett Heading ( Brisbane based chairman ), Dr Greg Collier ( Melbourne based CEO), and Dr Mitchell Glass ( US based CSO ) will have to spend time meeting with potential partners. That's what partnerships are built on, people. The science is good, I believe our people are good, so I am optimistic. Big pharma don't like negotiations in the public arena. My motto is stay quiet and carry a big stick, while my experience is that the emptiest vessels make the loudest noise. Mitchell, time to take the lab coat off and have another go at putting on a tie because you are our biggest asset.
IVX Price at posting:
0.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)